Switching NSAIDs in practice: Insights from the Previcox (firocoxib) experience trial

Veterinary Therapeutics

Volumn 8, Issue 4, 2007, Pages 263-271

  Ryan, William G ^a   Moldave, Katherine ^b   Carithers, Doug ^c  

^a Ryan Mitchell Associates   (United States)

^b AlcheraBio LLC   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

3 (CYCLOPROPYLMETHOXY) 4 (4 METHYLSULFONYLPHENYL) 5,5 DIMETHYLFURANONE; 3-(CYCLOPROPYLMETHOXY)-4-(4-METHYLSULFONYLPHENYL)-5,5-DIMETHYLFURANONE; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONE; UNCLASSIFIED DRUG; VETERINARY DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; DOG; DRUG ADMINISTRATION; FACTUAL DATABASE; METHODOLOGY; OSTEOARTHRITIS; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY;

4-BUTYROLACTONE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DOGS; DRUG ADMINISTRATION SCHEDULE; OSTEOARTHRITIS; PATIENT SELECTION; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SULFONES; VETERINARY DRUGS;

EID: 39749154167     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ryan WG, Moldave K, Carithers D: Clinical effectiveness and safety of a new NSAID, firocoxib: A 1,000 dog study. Vet Ther 7(2):119-126, 2006.
2. Mansa S, Palmer E, Grondahl C, et al: Long term treatment with carprofen of 805 dogs with osteoarthritis. Vet Rec 160:427-430, 2007.
3. Vane JR: The fight against rheumatism: From willow bark to COX-1 sparing drugs. J Physiol Pharm 51:573-586, 2000.
4. US FDA, Center for Veterinary Medicine: Current Labels for Animal Drugs and Animal Feed Products. Accessed November 17, 2007, at www.fda.gov/cvm/currentlabels.html.
5. Klauss G, Giuliano EA, Moore CP, et al: Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002). JAVMA 230:541-547, 2007.
6. Moreau M, Dupuis J, Bonneau NH, Desnoyers M: Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 152:323-329, 2003.
7. MacPhail CM, Lappin MR, Meyer DJ, et al: Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. JAVMA 212:1895-1901, 1998.
8. Nakagawa K, Yamagami T, Takemura N: Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam. in a Siberian husky. J. Vet Med Sci 67:1051-1053, 2005.
9. Hampshire VA, Doddy FM, Post LO, et al: Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine. JAVMA 225:533-536, 2004.
10. US FDA, Center for Veterinary Medicine: Cumulative Veterinary Adverse Drug Evperience (ADE) Reports. Accessed November 17, 2007, at www.fda.gov/cvm/ade_cum.htm.
11. Stanton ME, Bright RM: Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review. Vet Intern Med 3:238-244, 1989.
12. Hinton LE, McLoughlin MA, Johnson SE, et al: Spontaneous gastroduodenal perforation in 16 dogs and seven cars (1982-1999). JAAHA 38:176-187, 2002.
13. Lascelles BD, Blikslager AT, Fox SM, et al: Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase-2 inhibitor: 29 cases (2002-2003). JAVMA 227:1112-1117, 2005.
14. Lascelles BD, McFarland JM, Swann H: Guidelines for safe and effective use of NSAIDs in dogs. Vet Ther 6(3):237-251, 2005.
15. Lees P, Giraudel J, Landoni MF, Toutain PL: PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: Principles and applications in veterinary pharmacology. J Vet Pharmacol Ther 27:491-502, 2004.
16. Toutain PL, Lees P: Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. J Vet Pharmacol Ther 27:467-477, 2004.
17. Paulson SK, Engel L, Reitz B, et al: Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos 27:1133-1142, 1999.
18. Lees P, Landoni ME Giraudel J, Toutain PL: Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. J Vet Pharmacol Ther 27:491-502, 2004.
19. Dowers KL, Uhrig SR, Khursheed RM, et al: Effect of short-term sequential administration of nonsteroidal anti-inflammatory drugs on the stomach and proximal portion of the duodenum in healthy dogs. Am J Vet Res 67:1794-1801, 2006.
20. Fiorucci S, Santucci L, Wallace JL, et al: Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci 100:10937-10941, 2003.
21. Aragon CL, Hofmeister EH, Budsberg SC: Systematic review of clinical trials of treatments for osteoarthritis in dogs. JAVMA 230:514-521, 2007.